China-Europe Collaboration Brings New Hope for Cholangiocarcinoma Treatment – An Exclusive Interview with Dr. Chiara Braconi

China-Europe Collaboration Brings New Hope for Cholangiocarcinoma Treatment – An Exclusive Interview with Dr. Chiara Braconi

2025.02.28
From February 20 to 22, 2025, the European Association for the Study of the Liver (EASL) Liver Cancer Summit was held in Paris, France. The first day of the conference was dedicated to Cholangiocarcinoma (CCA). Dr. Chiara Braconi, a leading expert in cholangiocarcinoma treatment from the University of Glasgow, UK, delivered a keynote lecture and later sat down for an exclusive interview with our publication.
Research Progress丨Analysis of Platinum Intolerance and Treatment Outcomes in First-Line Treatment of Advanced Urothelial Carcinoma Patients

Research Progress丨Analysis of Platinum Intolerance and Treatment Outcomes in First-Line Treatment of Advanced Urothelial Carcinoma Patients

2025.02.28
Advanced urothelial carcinoma (UC) patients have a poor prognosis with a low 5-year survival rate. Since the 1980s, platinum-based chemotherapy has been the standard first-line therapy for locally advanced or metastatic UC (la/mUC), but the benefits are limited. The real-world tolerance and treatment outcomes of platinum therapy remain unclear. This year's study analyzed data from advanced UC patients in the United States. This article summarizes and organizes the findings for our readers.
Insightful Analysis and Future Blueprint: Academician Binghe Xu Highlights COMB, Outlining the Development of Innovative Breast Cancer Drugs in China

Insightful Analysis and Future Blueprint: Academician Binghe Xu Highlights COMB, Outlining the Development of Innovative Breast Cancer Drugs in China

2025.02.28
From August 2-4, 2024, the Seventh Tumor Precision Diagnosis and Treatment Conference and the Tenth Breast Cancer Individualized Treatment Conference (COMB), hosted by the China Cancer Foundation and the Beijing Breast Disease Prevention and Treatment Society, were grandly held in Beijing. The conference brought together the latest advancements in individualized precision treatment of breast cancer in China, providing a broad stage for promoting new concepts, developing new technologies, and creating new models in the breast cancer field. "Oncology Frontier" specially interviewed the chairman of the COMB conference, Academician Binghe Xu from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, to highlight the key points of COMB, outline the blueprint for the development of innovative breast cancer drugs in China, and guide the research directions for immunotherapy in breast cancer.
Celebrating World Breastfeeding Week!

Celebrating World Breastfeeding Week!

2025.02.28
Celebrating World Breastfeeding Week! From August 1st to 7th, we honor and support the beautiful journey of breastfeeding. Let's join hands to promote the importance of breastfeeding for both mothers and babies. It's more than just nourishment—it's about bonding, health, and giving our little ones the best start in life